Quantcast
Last updated on April 24, 2014 at 14:12 EDT

Latest Inflammatory breast cancer Stories

2011-10-24 12:06:26

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have discovered a new way to model human breast cancer that could lead to new tools for predicting which breast cancers will spread and new ways to test drugs that may stop its spread. Their results are published online today in the journal Nature Medicine. To create this improved model for breast cancer studies, the researchers grafted tumor tissue from consenting breast cancer patients directly into mouse mammary...

2011-10-18 17:45:00

By the National Cancer Institute BETHESDA, Md., Oct. 18, 2011 /PRNewswire-USNewswire/ -- October marks National Breast Cancer Awareness Month. Is there cause for celebration? For many reasons, the answer is a resounding "yes." Since 1990, the rate of death from breast cancer has been dropping. Research--much of it funded by the National Cancer Institute (NCI)--has improved our understanding of breast cancer and produced more effective treatments. (Logo:...

2011-10-17 17:08:24

Obese women develop breast cancer at a younger age than other women. Furthermore, the likelihood of developing breast cancer is much higher in patients with morbid obesity. This is one of the main conclusions drawn in an article recently published in the Spanish journal Nutrición Hospitalaria by the University of Granada research group CTS 367, coordinated by the Nursery Department professor María José Aguilar Cordero. The researchers examined a...

2011-09-13 07:00:00

REDWOOD CITY, Calif., Sept. 13, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of five studies covering breast and colon cancers that will be presented during poster sessions at the 2011 European Multidisciplinary Cancer Congress, September 23-27, in Stockholm, Sweden. Breast cancer presentations include health economics analysis of seven studies in six countries supporting Oncotype DX's cost effectiveness across various healthcare systems. Breast cancer...

2011-08-10 08:00:00

IRVINE, California and AMSTERDAM, August 10, 2011 /PRNewswire/ -- Agendia, a commercial-stage molecular cancer diagnostics company, today announced that the 12th St. Gallen International Breast Cancer Conference (2011) Expert Panel's recommendations highlight the value of molecular subtyping - classifying patients by the particular biological subtype of their tumor - in guiding treatment decisions for breast cancer patients. According to the panel, "it is no longer tenable to...

2011-07-05 06:40:00

ATLANTA, July 5, 2011 /PRNewswire/ -- Earlier this year, the Food and Drug Administration (FDA) reviewed a possible link between breast implants and a rare type of cancer (anaplastic large cell lymphoma, or ALCL). ALCL rarely develops in the breast, according to the National Cancer Institute. The FDA is currently aware of only 60 cases worldwide, a tiny fraction of the millions of women who have received breast implants. As additional data is needed, the FDA has asked health care...

2011-05-16 19:23:21

Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict a breast cancer patients' risk of cancer recurrence. This breakthrough may lead to new genetic testing that further personalizes breast cancer care. The study, published in the journal Breast Cancer Research and Treatment, is the first to use tumor infiltrating immune cells located at the site of the tumor to predict cancer recurrence....

2011-04-22 00:00:29

Recent research indicates medications such as Tamoxifen or Raloxifene considerably reduce the risk of developing breast cancer in post-menopausal women. MapleLeafMeds is a reputable source for quality drugs like Tamoxifen that doctors believe may slash the risk of breast cancer by up to 43%. Vancouver, BC (PRWEB) April 21, 2011 A recent article in the Lancet Oncology by a panel of cancer experts concluded that women in the higher risk categories for breast cancer could benefit from drugs...

2011-03-15 07:54:10

(Ivanhoe Newswire) "“ Tamoxifen, taken by women as a preventive measure against breast cancer, sufficiently compensates for its side effects in post-menopausal women under the age of 55 years, according to this study. Research has shown that tamoxifen can protect against breast cancer for years after treatment ends, but identifying the group of women who can most benefit from the drug as a cancer preventive agent, without experiencing serious side effects, is a challenge. Side effects...

2011-03-14 14:17:10

Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that the benefits of tamoxifen to prevent cancer can sufficiently compensate for its side effects in post-menopausal women under age 55 years who have an increased risk of developing breast cancer. Research has shown that...